Literature DB >> 10200910

Regulation and regulatory activities of transforming growth factor beta.

L F Bonewald1.   

Abstract

Transforming growth factor beta (TGF beta) is unique among growth factors in its potent and widespread actions. Almost every cell in the body has been shown to make some form of TGF beta, and almost every cell has receptors for TGF beta. Therefore, it becomes apparent that this growth factor must be tightly regulated to prevent disease. The mechanisms of regulation of TGF beta are extensive and complex. One set of mechanisms centers around the fact that TGF beta is produced in a latent form that must be activated to produce biologically active TGF beta. These mechanisms include the latency of the molecule, the production of various latent forms, its targeting to cells for activation or to matrix for storage, and the means of activation of the latent forms. The TGF beta isoforms and the types, affinity, and signaling functions of its receptors also add complexity to the regulation of the effects of TGF beta. Active TGF beta regulates numerous processes in the body. TGF beta has three major biological effects: growth inhibition, stimulation of extracellular matrix formation, and immunosuppression. The means by which TGF beta regulates the expression of the numerous genes on which it has effects are complex and more information is needed. The means by which TGF beta regulates gene expression and the means by which the actions of TGF beta are regulated are addressed in this review.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10200910

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  20 in total

1.  Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair.

Authors:  C Soo; F Y Hu; X Zhang; Y Wang; S R Beanes; H P Lorenz; M H Hedrick; R J Mackool; A Plaas; S J Kim; M T Longaker; E Freymiller; K Ting
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells.

Authors:  Bo Jian; Jie Xu; Jeanne Connolly; Rashmin C Savani; Navneet Narula; Bruce Liang; Robert J Levy
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Exercise-induced changes in circulating levels of transforming growth factor-beta-1 in humans: methodological considerations.

Authors:  Katja Heinemeier; Henning Langberg; Michael Kjaer
Journal:  Eur J Appl Physiol       Date:  2003-07-09       Impact factor: 3.078

Review 4.  The effects of dietary protein and amino acids on skeletal metabolism.

Authors:  Jessica D Bihuniak; Karl L Insogna
Journal:  Mol Cell Endocrinol       Date:  2015-04-02       Impact factor: 4.102

5.  Evidence for the involvement of dietary lipids on the modulation of transforming growth factor-beta1 in the platelets of male rats.

Authors:  J M Adam; J Raju; N Khalil; R P Bird
Journal:  Mol Cell Biochem       Date:  2000-08       Impact factor: 3.396

6.  X-irradiation-induced cell cycle delay and DNA double-strand breaks in the murine osteoblastic cell line OCT-1.

Authors:  Patrick Lau; Christa Baumstark-Khan; Christine E Hellweg; Günther Reitz
Journal:  Radiat Environ Biophys       Date:  2010-03-16       Impact factor: 1.925

7.  Fibrillins 1 and 2 perform partially overlapping functions during aortic development.

Authors:  Luca Carta; Lygia Pereira; Emilio Arteaga-Solis; Sui Y Lee-Arteaga; Brett Lenart; Barry Starcher; Christian A Merkel; Marina Sukoyan; Alexander Kerkis; Noriko Hazeki; Douglas R Keene; Lynn Y Sakai; Francesco Ramirez
Journal:  J Biol Chem       Date:  2005-12-28       Impact factor: 5.157

Review 8.  Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases.

Authors:  A Sabokbar; D J Mahoney; F Hemingway; N A Athanasou
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

9.  Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.

Authors:  Ronald V Lacro; Harry C Dietz; Lisa M Wruck; Timothy J Bradley; Steven D Colan; Richard B Devereux; Gloria L Klein; Jennifer S Li; L LuAnn Minich; Stephen M Paridon; Gail D Pearson; Beth F Printz; Reed E Pyeritz; Elizabeth Radojewski; Mary J Roman; J Philip Saul; Mario P Stylianou; Lynn Mahony
Journal:  Am Heart J       Date:  2007-10       Impact factor: 4.749

10.  Homeostatic role of transforming growth factor-beta in the oral cavity and esophagus of mice and its expression by mast cells in these tissues.

Authors:  Allison Vitsky; James Waire; Robert Pawliuk; Arden Bond; Douglas Matthews; Emily Lacasse; Michael L Hawes; Carol Nelson; Susan Richards; Peter A Piepenhagen; Richard D Garman; Laura Andrews; Beth L Thurberg; Scott Lonning; Steve Ledbetter; Melanie C Ruzek
Journal:  Am J Pathol       Date:  2009-04-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.